Gene · 406892
Papers3,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to "Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J" [DNA Repair 9 (2010) 1170-1175]. | DNA Repair (Amst) | 2024 | 38217905 | PubTator, text mining | PubMed |
| Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer. | Cell Mol Life Sci | 2024 | 38212428 | PubTator, text mining | PubMed |
| Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease. | Nutrients | 2024 | 38201989 | PubTator, text mining | PubMed |
| Tumor hypoxia and role of hypoxia-inducible factor in oral cancer. | World J Surg Oncol | 2024 | 38200568 | PubTator, text mining | PubMed |
| miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease. | Alzheimers Res Ther | 2024 | 38195609 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. | Nat Commun | 2024 | 38191557 | PubTator, text mining | PubMed |
| Non-coding RNA in the gut of the blood-feeding parasitic worm, Haemonchus contortus. | Vet Res | 2024 | 38172997 | PubTator, text mining | PubMed |
| Genetic variants rs2910164, rs4636297 and rs895819 may contribute to the onset of acute myocardial infarction in Pakistani population. | PLoS One | 2024 | 38165852 | PubTator, text mining | PubMed |
| miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma. | Noncoding RNA Res | 2024 | 38075204 | PubTator, text mining | PubMed |
| A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome. | Obstet Gynecol Sci | 2024 | 38050353 | PubTator, text mining | PubMed |
| Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways. | Cancer Sci | 2024 | 37972389 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection. | Eur J Hum Genet | 2024 | 37938797 | PubTator, text mining | PubMed |
| Effects of extracellular vesicle-derived noncoding RNAs on pre-metastatic niche and tumor progression. | Genes Dis | 2024 | 37588211 | PubTator, text mining | PubMed |
| The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a. | Mol Biotechnol | 2024 | 37087718 | PubTator, text mining | PubMed |
| Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors. | Mol Cell Biochem | 2024 | 37016182 | PubTator, text mining | PubMed |
| Evaluation of MicroRNA as Minimal Residual Disease in Leukemia: Diagnostic and Prognostic Approach: A Review. | Iran J Public Health | 2023 | 38435763 | PubTator, text mining | PubMed |
| Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans. | Genes (Basel) | 2023 | 38275601 | PubTator, text mining | PubMed |
| Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. | Front Pharmacol | 2023 | 38269272 | PubTator, text mining | PubMed |
| The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy. | Front Oncol | 2023 | 38250549 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406892/papers?page=5